Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Spectrum Pharmaceuticals

10/05/2023 13:01

* Spectrum Pharmaceuticals Inc  SPPI.OQ  reported a
quarterly
adjusted loss of 2 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 6 cents per share.
    * Revenue was $15.62 million​; analysts expected $10.97
million. 
    * Spectrum Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 2 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Spectrum Pharmaceuticals Inc shares had risen by 60.0%
this
quarter and gained 225.6% so far this year.
    * The company reported a quarterly loss of $5.01 million.
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $1.14 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 12:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.06          -0.02          Beat
 Dec. 31 2022      -0.11          -0.05          Beat
 Sep. 30 2022      -0.15          -0.12          Beat
 Jun. 30 2022      -0.16          -0.17          Missed